A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis
Clinical trial NCT05437263 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05437263
- Sponsor
- Priovant Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-31
- Primary completion
- 2025-07-17
- Enrollment
- 241
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.